Use access key #2 to skip to page content.
$3.19 -0.31 (-8.86%)
11/21/2008 11:51 AM

MannKind Corp (MNKD)

CAPS Rating:
**

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

View All Commentary (MNKD)

Recs

0

Avatar snivle77 (51.33) Submitted: 4/11/08 9:25 AM : Underperform Start Price: $2.58 MNKD Score: -60.43

Their one and only product is taking a dive

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links